GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

Development follows company’s ₹350-crore investment in India to expand research, manufacturing, and sustainability-led ...

Jungbunzlauer, a global leader in high-quality, sustainable ingredients, and Professor Karl Wagner from the University of ...

President Luong Cuong affirmed that Vietnam always creates the best possible conditions for foreign enterprises, including ...

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...

The Contrast Media Market is expected to experience a steady growth rate of 5-6% CAGR. Key drivers of this growth include innovations in imaging technologies, the rising incidence of chronic ...

The "Every Breath You Take" singer will perform in San Francisco as part of a two-night extravaganza two days before Bad Bunny's halftime show. Last month, Jamie Lee Curtis could not hold back her ...

Achieved commercially viable yield for IM1240, positioning the program competitively for future developmentValidates ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Chong Kun Dang recently announced plans to invest 2.2 trillion Korean won to establish a state-of-the-art biopharmaceutical ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...